Antonio G Pacheco

Summary

Affiliation: Rio de Janeiro
Country: Brazil

Publications

  1. pmc Genetic polymorphisms of infectious diseases in case-control studies
    Antonio G Pacheco
    Programa de Computacao Cientifica, FIOCRUZ, Av Brasil, 4365, Manguinhos, 21045 360 Rio de Janeiro, RJ, Brazil
    Dis Markers 27:173-86. 2009
  2. pmc Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil
    Antonio G Pacheco
    Department of Epidemiology and Quantitative Methods in Health, National School of Public Health Scientific Computing Program, Oswaldo Cruz Foundation FIOCRUZ, Rio de Janeiro, Brazil
    PLoS ONE 3:e1531. 2008
  3. pmc Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil
    Antonio G Pacheco
    FIOCRUZ, Rio de Janeiro, Brazil
    AIDS Res Hum Retroviruses 27:25-8. 2011
  4. pmc Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil
    Antonio G Pacheco
    Programa de Computacao Cientifica, Fundacao Oswaldo Cruz, Avenida Brasil 4365, Manguinhos, 21045 360 Rio de Janeiro, Brazil
    Am J Epidemiol 168:1326-32. 2008
  5. pmc Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil
    Antonio G Pacheco
    Department of Epidemiology and Quantitative Methods in Health, National School of Public Health, FIOCRUZ, Brazil
    J Acquir Immune Defic Syndr 51:624-30. 2009
  6. pmc Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial
    Betina Durovni
    Municipal Health Secretariat, Rio de Janeiro, Brazil Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
    Lancet Infect Dis 13:852-8. 2013
  7. pmc Continuous Increase of Cardiovascular Diseases, Diabetes, and Non-HIV Related Cancers as Causes of Death in HIV-Infected Individuals in Brazil: An Analysis of Nationwide Data
    Adelzon A Paula
    Programa de Computacao Cientifica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brasil
    PLoS ONE 9:e94636. 2014
  8. pmc The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study
    Betina Durovni
    Municipal Health Secretariat, Rio de Janeiro, Rio de Janeiro, Brazil
    AIDS 24:S49-56. 2010
  9. ncbi request reprint Impact of Isoniazid Preventive Therapy for HIV-Infected Adults in Rio de Janeiro, Brazil: An Epidemiological Model
    David W Dowdy
    Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Subsecretariat for Primary Care, Surveillance, and Health Promotion, Municipal Health Secretariat, Rio de Janeiro, Brazil Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Program of Scientific Computing, FIOCRUZ, Rio de Janeiro, Brazil Evandro Chagas Institute of Clinical Research, FIOCRUZ, Rio de Janeiro, Brazil and Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
    J Acquir Immune Defic Syndr 66:552-8. 2014
  10. pmc AIDS-related tuberculosis in Rio de Janeiro, Brazil
    Antonio G Pacheco
    ENSP PROCC, FIOCRUZ, Rio de Janeiro, Brazil
    PLoS ONE 3:e3132. 2008

Collaborators

  • Jonathan E Golub
  • Valeria Saraceni
  • Mauro Schechter
  • Lee H Harrison
  • Beatriz Grinsztejn
  • L H Moulton
  • Estevão P Nunes
  • Euzenir Nunes Sarno
  • RICHARD DOUGLAS MOORE
  • Paula M Luz
  • Betina Durovni
  • Silvia Cohn
  • Richard E Chaisson
  • Solange C Cavalcante
  • David W Dowdy
  • Adelzon A Paula
  • Carolinne de Sales Marques
  • Bonnie S King
  • Anne Efron
  • Lucia H L V Amim
  • Adalberto R Santos
  • Joseane Fonseca-Costa
  • Fernanda C Q Mello
  • Marcelo F Rabahi
  • Afranio L Kritski
  • Raquel L F Teixeira
  • Valdilea G Veloso
  • Suely H Tuboi
  • Ronaldo I Moreira
  • Jose Claudio Faulhaber
  • João H Martins
  • Patricia Gigliotti
  • Jose Augusto C Nery
  • Ernesto Raul Caffarena
  • Milton Ozório Moraes
  • Weber Laurentino da Silva
  • Francisco C F Lana
  • Vânia N Brito-de-Souza
  • Priscila Medeiros
  • Luana Tatiana Albuquerque Guerreiro
  • Evaldo P Amaral
  • Ana Paula Campanelli
  • Ida Maria Foschiani Dias-Batista
  • Marcelo T Mira
  • Ana Carla Pereira
  • Marcos Virmond
  • Cynthia C Cardoso
  • Giselle Israel
  • Vitoria Vellozo
  • Fernando C V Ribeiro
  • Maria H Melo
  • Martha M Oliveira
  • Jose R Lapa e Silva
  • Tom H Ottenhoff
  • Carla S Loredo
  • Antonio B Miranda
  • Hedi M Melo
  • Philip N Suffys
  • Márcia Q P Lopes

Detail Information

Publications17

  1. pmc Genetic polymorphisms of infectious diseases in case-control studies
    Antonio G Pacheco
    Programa de Computacao Cientifica, FIOCRUZ, Av Brasil, 4365, Manguinhos, 21045 360 Rio de Janeiro, RJ, Brazil
    Dis Markers 27:173-86. 2009
    ....
  2. pmc Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil
    Antonio G Pacheco
    Department of Epidemiology and Quantitative Methods in Health, National School of Public Health Scientific Computing Program, Oswaldo Cruz Foundation FIOCRUZ, Rio de Janeiro, Brazil
    PLoS ONE 3:e1531. 2008
    ....
  3. pmc Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil
    Antonio G Pacheco
    FIOCRUZ, Rio de Janeiro, Brazil
    AIDS Res Hum Retroviruses 27:25-8. 2011
    ....
  4. pmc Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil
    Antonio G Pacheco
    Programa de Computacao Cientifica, Fundacao Oswaldo Cruz, Avenida Brasil 4365, Manguinhos, 21045 360 Rio de Janeiro, Brazil
    Am J Epidemiol 168:1326-32. 2008
    ..These results indicate that the algorithm is accurate enough to recover vital status information on patients lost to follow-up in cohort studies...
  5. pmc Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil
    Antonio G Pacheco
    Department of Epidemiology and Quantitative Methods in Health, National School of Public Health, FIOCRUZ, Brazil
    J Acquir Immune Defic Syndr 51:624-30. 2009
    ..The widespread use of highly active antiretroviral therapy (HAART) has led to marked decreases in death rates in Brazil in HIV-infected individuals. Nonetheless, there are scarce data on specific causes of death...
  6. pmc Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial
    Betina Durovni
    Municipal Health Secretariat, Rio de Janeiro, Brazil Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
    Lancet Infect Dis 13:852-8. 2013
    ..We assessed the effect of widespread use of isoniazid preventive therapy on rates of tuberculosis and death in people with HIV in Brazil...
  7. pmc Continuous Increase of Cardiovascular Diseases, Diabetes, and Non-HIV Related Cancers as Causes of Death in HIV-Infected Individuals in Brazil: An Analysis of Nationwide Data
    Adelzon A Paula
    Programa de Computacao Cientifica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brasil
    PLoS ONE 9:e94636. 2014
    ..Herein we extend previous observations from a nationwide survey on temporal trends in causes of death in HIV-infected patients in Brazil...
  8. pmc The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study
    Betina Durovni
    Municipal Health Secretariat, Rio de Janeiro, Rio de Janeiro, Brazil
    AIDS 24:S49-56. 2010
    ..The TB/HIV in Rio (THRio) study was launched in September 2005 to assess the impact of integrated tuberculosis (TB) and HIV treatment strategies in 29 HIV clinics in Rio de Janeiro, Brazil...
  9. ncbi request reprint Impact of Isoniazid Preventive Therapy for HIV-Infected Adults in Rio de Janeiro, Brazil: An Epidemiological Model
    David W Dowdy
    Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Subsecretariat for Primary Care, Surveillance, and Health Promotion, Municipal Health Secretariat, Rio de Janeiro, Brazil Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Program of Scientific Computing, FIOCRUZ, Rio de Janeiro, Brazil Evandro Chagas Institute of Clinical Research, FIOCRUZ, Rio de Janeiro, Brazil and Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
    J Acquir Immune Defic Syndr 66:552-8. 2014
    ..The potential epidemiological impact of isoniazid preventive therapy (IPT), delivered at levels that could be feasibly scaled up among people living with HIV (PLHIV) in modern, moderate-burden settings, remains uncertain...
  10. pmc AIDS-related tuberculosis in Rio de Janeiro, Brazil
    Antonio G Pacheco
    ENSP PROCC, FIOCRUZ, Rio de Janeiro, Brazil
    PLoS ONE 3:e3132. 2008
    ..We studied the incidence of tuberculosis, AIDS, AIDS deaths and AIDS-TB co-infection at the population level in Rio de Janeiro, Brazil where universal and free access to combination antiretroviral therapy has been available since 1997...
  11. pmc Long-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy
    Paula M Luz
    Instituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brasil
    PLoS ONE 9:e93039. 2014
    ....
  12. pmc Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era
    Beatriz Grinsztejn
    Instituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brasil
    PLoS ONE 8:e59768. 2013
    ..We describe temporal trends in the mortality rates and factors associated with AIDS and non-AIDS related mortality at the Evandro Chagas Clinical Research Institute (IPEC), Oswaldo Cruz Foundation (FIOCRUZ)...
  13. ncbi request reprint Role of IFN-gamma +874 T/A single nucleotide polymorphism in the tuberculosis outcome among Brazilians subjects
    Lucia H L V Amim
    HUCFF IDT Complex Federal University of Rio de Janeiro, Rua Professor Rodolpho Paulo Rocco 255, Ilha do Fundao, Rio de Janeiro, 21941 590, Brazil
    Mol Biol Rep 35:563-6. 2008
    ....
  14. doi request reprint Toll-like receptor 1 N248S single-nucleotide polymorphism is associated with leprosy risk and regulates immune activation during mycobacterial infection
    Carolinne de Sales Marques
    Laboratório de Hanseníase, Instituto Oswaldo Cruz, Av Brasil 4365, Manguinhos Rio de Janeiro, RJ, Brazil
    J Infect Dis 208:120-9. 2013
    ..Our results suggest that TLR1 248S is associated with an increased risk for leprosy, consistent with its hypoimmune regulatory function...
  15. ncbi request reprint Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil
    Raquel L F Teixeira
    Laboratory of Molecular Biology Applied to Mycobacteria, Department of Mycobacteriosis, IOC FIOCRUZ, Avenida Brasil 4365, Manguinhos, Rio de Janeiro, CEP 21040 900, Brazil
    Mutat Res 624:31-40. 2007
    ..This finding has implications in the determination of nationwide policies for use of appropriate anti-TB drugs...
  16. pmc The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil
    Jonathan E Golub
    Center for Tuberculosis Research, Johns Hopkins University, Baltimore, Maryland 21231, USA
    AIDS 21:1441-8. 2007
    ..Antiretroviral therapy (ART) lowers the risk of tuberculosis, but may not be sufficient to control HIV-related tuberculosis. Isoniazid preventive therapy (IPT) reduces tuberculosis incidence significantly, but is not widely used...
  17. ncbi request reprint Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention
    Lawrence H Moulton
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 20912, USA
    Clin Trials 4:190-9. 2007
    ..In practice, although Brazil is a model for provision of antiretroviral therapy to patients with advanced HIV disease, relatively few such patients receive TB testing and prevention services...